Nanoviricides (NNVC) Operating Income (2010 - 2026)
Nanoviricides (NNVC) posted Operating Income of -$2.25 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$2.12 million a year earlier.
Powered by 
Analysis
Nanoviricides (NNVC) Operating Income (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides' Operating Income came in at -$8.31 million.
- In prior fiscal years, Nanoviricides' Operating Income was -$9.59 million in FY2025, -$8.52 million in FY2024, -$8.94 million in FY2023 and -$8.11 million in FY2022.
- The fiscal Q4 2026 figure stands as the lowest quarterly Operating Income since fiscal Q3 2025.
- According to Business Quant data, Operating Income for the three prior fiscal quarters was -$2.03 million (Q3 2026), -$2.23 million (Q2 2026) and -$1.8 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Nanoviricides | 30.08 Mn | 17.74 Mn | - | -2.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.25 Mn |
| Mar 31, 2026 | -2.03 Mn |
| Dec 31, 2025 | -2.23 Mn |
| Sep 30, 2025 | -1.80 Mn |
| Jun 30, 2025 | -2.12 Mn |
| Mar 31, 2025 | -2.25 Mn |
| Dec 31, 2024 | -2.06 Mn |
| Sep 30, 2024 | -3.17 Mn |
| Jun 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -1.91 Mn |
| Dec 31, 2023 | -2.18 Mn |
| Sep 30, 2023 | -2.03 Mn |
| Jun 30, 2023 | -3.68 Mn |
| Mar 31, 2023 | -1.81 Mn |
| Dec 31, 2022 | -1.83 Mn |
| Sep 30, 2022 | -1.62 Mn |
| Jun 30, 2022 | -1.79 Mn |
| Mar 31, 2022 | -1.79 Mn |
| Dec 31, 2021 | -1.92 Mn |
| Sep 30, 2021 | -2.61 Mn |
API Access
Nanoviricides Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();